非裔美国种族与主动监测期间病理重新分类风险无关:Canary前列腺癌主动监测研究结果
该研究基于Canary PASS前瞻性多中心主动监测队列,纳入1315例低危前列腺癌患者,其中非裔美国男性89例(7%)。多因素Cox模型显示非裔美国种族与重新分类风险无关(HR 1.16,95%CI 0.78-1.72),且延迟根治术后不良病理率与白人相似(46% vs 47%,p=0.99)。结论认为主动监测是非裔美国低危前列腺癌患者的合适管理策略。
要点
- 非裔美国男性在主动监测期间病理重新分类风险与白人无显著差异。
- 延迟根治性前列腺切除术后不良病理发现率两组相似(46% vs 47%)。
- 主动监测可作为非裔美国低危前列腺癌患者的合适管理策略。
核心结论
- 在遵循标准化主动监测方案的非裔美国男性中,病理重新分类风险未增加。
- 非裔美国男性延迟根治性前列腺切除术后不良病理发现率与白人相似。
- 主动监测是非裔美国低危前列腺癌患者的合适管理策略。
研究设计与样本
- Canary PASS为前瞻性多中心主动监测队列,采用预设PSA和监测活检方案。
- 纳入诊断时Gleason分级分组1或2、诊断至入组间隔小于5年且至少接受1次监测活检的男性。
- 共纳入1315例男性,非裔美国89例(7%),白人1226例(93%)。
- 采用Cox比例风险模型比较重新分类风险,并在延迟根治术亚组中比较不良病理率。
主要发现
- 非裔美国与白人男性的治疗率无差异。
- 多因素模型中非裔美国种族与重新分类风险无关(HR 1.16,95%CI 0.78-1.72)。
- 441例延迟根治性前列腺切除术后,非裔美国与白人不良病理率相似(46% vs 47%,p=0.99)。
关键数值与推荐
- 重新分类定义为后续活检Gleason评分升高。
- 不良病理定义为pT3a或更高分期,或Gleason分级分组3或更高。
临床怎么用
- 对于低危前列腺癌的非裔美国男性,主动监测可作为合适的管理选择。
- 遵循标准化PSA检测和活检方案的主动监测不会增加非裔美国男性的重新分类风险。
局限性
- 非裔美国男性样本量相对较小(89例)。
- 延迟根治术亚组分析样本有限(441例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In a large, prospective, multi-institutional active surveillance cohort we evaluated whether African American men are at higher risk for reclassification. MATERIALS AND METHODS: The Canary PASS (Prostate Active Surveillance Study) is a protocol driven, active surveillance cohort with a prespecified prostate specific antigen and surveillance biopsy regimen. Men included in this study had Gleason Grade Group 1 or 2 disease at diagnosis and fewer than 5 years between diagnosis and enrollment, and had undergone 1 or more surveillance biopsies. The reclassification risk, defined as an increase in the Gleason score on subsequent biopsy, was compared between African American and Caucasian American men using Cox proportional hazards models. In the subset of men who underwent delayed prostatectomy the rate of adverse pathology findings, defined as pT3a or greater disease, or Gleason Grade Group 3 or greater, was compared in African American and Caucasian American men. RESULTS: Of the 1,315 men 89 (7%) were African American and 1,226 (93%) were Caucasian American. There was no difference in the treatment rate in African American and Caucasian American men. In multivariate models African American race was not associated with the risk of reclassification (HR 1.16, 95% CI 0.78-1.72). Of the 441 men who underwent prostatectomy after a period of active surveillance the rate of adverse pathology was similar in those who were African American and Caucasian American (46% vs 47%, p=0.99). CONCLUSIONS: Of men on active surveillance who followed a standardized protocol of regular prostate specific antigen testing and biopsy those who were African American were not at increased risk for pathological reclassification while on active surveillance, or for adverse pathology findings at prostatectomy. Active surveillance appears to be an appropriate management strategy for African American men with favorable risk prostate cancer.
引用
- Schenk JM, Newcomb LF, Zheng Y, et al. African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study. J Urol. 2019. PMID: 31651227. doi:10.1097/JU.0000000000000621
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。